Daily Peanut Consumption May Enhance Brain Insulin Sensitivity in Older Adults
A new study reveals that consuming unsalted, skin-roasted peanuts daily for 16 weeks improves insulin responsiveness in key memory-related brain regions among older adults. This enhanced sensitivity may help counteract age-related cognitive decline and reduce Alzheimer’s risk. The findings highlight a dietary strategy with potential neuroprotective benefits.
A 2026 study led by Dr. Peter Joris at Maastricht University Medical Center’s NUTRIM institute found that older adults aged 60 to 75 who consumed 60 grams (about two servings) of unsalted, skin-roasted peanuts daily for 16 weeks showed improved insulin responsiveness in key memory-related brain regions, including the hippocampus and posterior cingulate gyrus. Using arterial spin labeling MRI, researchers measured changes in regional cerebral blood flow after intranasal insulin administration, revealing enhanced brain insulin sensitivity—particularly in the right hemisphere. This builds on Joris’s 2025 research showing that the same regimen increased cerebral blood flow by 3.6% and improved verbal memory performance by 5.8%. The study was a randomized, controlled crossover trial involving 31 participants, with peanut consumption monitored via premeasured packets provided by researchers. Participants avoided peanuts during the control phase before switching to the intervention phase. The findings were published in Food & Function and supported by The Peanut Institute.
The research is rooted in growing evidence that insulin resistance in the brain—sometimes called "type 3 diabetes"—is linked to cognitive decline and Alzheimer’s disease. Insulin supports neuronal survival, synaptic function, and memory consolidation. As aging reduces brain insulin sensitivity, interventions that restore it may delay or prevent neurodegeneration. Peanuts’ potential benefits are attributed to a co
This study could influence public health messaging around diet and aging, potentially encouraging older adults to include peanuts as part of a brain-healthy lifestyle. Given the widespread availability and low cost of peanuts, such recommendations may be particularly impactful in primary care and preventive medicine settings. The findings may also affect food industry trends, with manufacturers possibly highlighting neuroprotective claims on peanut products, though regulatory scrutiny would likely follow. Comparable to the earlier public health shift promoting omega-3s for heart health, this research could catalyze a broader cultural emphasis on specific foods for cognitive longevity. However, it remains unclear whether similar benefits would be seen in individuals with pre-existing insulin resistance or early-stage dementia. Researchers may next investigate whether peanut consumption can delay cognitive decline in at-risk populations or interact with other dietary patterns like the Me